5 Mistakes Patients Make in Glaucoma Care

The five most common mistakes glaucoma patients make are: stopping eye drops when vision feels stable, missing follow-up appointments, ignoring family risk, self-managing side effects without telling their doctor, and assuming normal eye pressure means they are safe. Each mistake can silently accelerate nerve damage before any symptom appears, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Glaucoma is called the silent thief of sight for a reason. Most patients feel nothing until the damage is severe. That silence is exactly what makes certain habits so dangerous. These five mistakes are not careless choices. They are logical responses to a disease that gives no pain, no blur, and no warning. Understanding why each mistake happens is the first step to avoiding it.


5 Mistakes Glaucoma Patients Commonly Make

Mistake 1: Stopping Eye Drops When Vision Feels Fine

What patients do: They use drops for a few weeks, vision feels unchanged, and the drops get quietly abandoned. Life gets busy. The bottle runs out. It feels pointless to medicate something that causes no symptoms.

Why this is dangerous: Glaucoma drops do not improve vision. They protect the optic nerve from further damage. Stopping them does not feel like anything in the short term. But intraocular pressure rises within days of missing doses, and nerve damage accumulates silently over months.

What doctors often miss saying: Patients are rarely told that the goal of treatment is preservation, not improvement. When that is not explained clearly, stopping drops feels like a rational choice.

Real-world picture: Studies show that over 50% of glaucoma patients have poor drop adherence within one year of diagnosis. Many do not tell their doctor. Pressure readings at clinic visits look normal because patients resume drops a few days before their appointment.


Mistake 2: Skipping Follow-Up Appointments

What patients do: They feel well, work is busy, travel is expensive, and the appointment gets pushed by a month, then three months, then indefinitely.

Why this is dangerous: Glaucoma progression is invisible to the patient. Visual field loss in early and moderate glaucoma occurs in the peripheral vision first. Patients do not notice it in daily life. Only structured testing at follow-up reveals whether the nerve is stable or declining.

What doctors often miss saying: The frequency of follow-up is not arbitrary. It is calibrated to the rate of progression risk. Missing two visits in a year can mean missing a window to escalate treatment before irreversible loss occurs.

Real-world picture: A patient who feels fine and delays follow-up for six months may arrive to find their visual field has worsened by a measurable step. That step cannot be reversed.


Mistake 3: Ignoring Family History as a Personal Risk Signal

What patients do: A parent or sibling has glaucoma. The patient assumes they will know if they develop it too. They wait for symptoms before seeking screening.

Why this is dangerous: A first-degree family history of glaucoma increases personal risk by four to nine times. Glaucoma runs in families and often presents a decade earlier in the next generation. Waiting for symptoms means waiting until 30 to 40 percent of nerve fibres are already gone.

What doctors often miss saying: Screening is not just for people who already have symptoms. It is most valuable precisely when there are no symptoms yet.

Real-world picture: Many patients present to a glaucoma clinic only after a family member goes blind. By that point their own disease is already moderate or advanced.


Mistake 4: Managing Side Effects Silently Instead of Telling the Doctor

What patients do: Eye drops cause redness, stinging, darkened lashes, or a persistent dry eye feeling. Patients tolerate it quietly or stop the drops without informing anyone. They assume this is just how glaucoma treatment feels.

Why this is dangerous: Side effects are one of the most common reasons for treatment failure. Patients who stop drops due to side effects but do not report it appear adherent on their records. Pressure goes uncontrolled. The doctor has no reason to switch the formulation or try a preservative-free option.

What doctors often miss saying: There are multiple drop classes, combination formulations, and preservative-free alternatives. No patient needs to tolerate a drop that makes their eyes miserable. Laser treatment is also a first-line option that removes the drop burden entirely for many patients.

Real-world picture: A switch from a preserved to a preservative-free prostaglandin analogue resolves surface irritation in most patients within four to six weeks. Many patients never knew this option existed.


Mistake 5: Believing Normal Eye Pressure Means No Glaucoma Risk

What patients do: They have an eye check, are told pressure is normal, and conclude they do not have glaucoma and never will.

Why this is dangerous: Normal tension glaucoma is a well-documented condition in which nerve damage progresses despite intraocular pressure within the statistically normal range. In South Asian and East Asian populations this pattern is particularly common. Additionally, what is normal for the population may not be safe for a specific individual nerve.

What doctors often miss saying: Glaucoma diagnosis requires examination of the optic nerve, retinal nerve fibre layer imaging, and visual field testing. Pressure alone does not rule it out.

Real-world picture: Normal tension glaucoma accounts for a significant proportion of glaucoma in India. Patients with a normal pressure reading and a cupped nerve need full evaluation, not reassurance.


What This Table Shows You

MistakeWhat Patients BelieveThe Clinical Reality
Stopping dropsVision is stable so drops are not neededDrops preserve nerve, not vision
Missing follow-upNo symptoms means no progressionProgression is invisible without testing
Ignoring family historySymptoms will warn them in timeRisk is high and silent from the start
Tolerating side effectsThis is how treatment always feelsAlternatives exist; tell your doctor
Trusting normal pressureNormal IOP means no glaucomaNormal tension glaucoma is common in India

When to Worry

Seek an urgent glaucoma review if you notice any of the following. Sudden eye pain or headache with blurred vision and halos around lights. A family member has been recently diagnosed with glaucoma. Your vision seems to have narrowed or you are missing objects at the side. You have been using drops irregularly for more than one month. You have not had an optic nerve assessment in over a year.


What This Means for You

Glaucoma is manageable. Most patients who lose vision do so not because treatment failed but because the disease was caught late, treatment was abandoned, or follow-up was missed. None of these are irreversible situations if caught in time. The single most protective thing you can do is stay engaged with your care even when everything feels normal.


Frequently Asked Questions

Can glaucoma get worse even if I use my drops every day?

Yes. Drops reduce intraocular pressure but progression can continue in some patients despite good pressure control. This is why regular follow-up and nerve imaging remain essential even with perfect adherence.

How often should a glaucoma patient see their doctor?

Most stable patients need review every three to six months. Patients with active progression or recent treatment changes may need monthly visits. Your doctor will set the schedule based on your specific risk.

Is glaucoma hereditary and should my children be tested?

Yes, glaucoma has a strong hereditary component. First-degree relatives of a glaucoma patient should have a full eye examination including optic nerve assessment from the age of 35, or earlier if they have other risk factors.

What should I do if my eye drops are causing side effects?

Tell your doctor at the next visit and do not stop drops without guidance. There are multiple formulations, preservative-free options, and laser alternatives that may suit you better. Side effects are a solvable problem.

Does normal eye pressure rule out glaucoma?

No. Normal tension glaucoma is well recognised and common in Indian patients. A complete glaucoma evaluation includes optic nerve examination and imaging, not pressure measurement alone.


Speak to a Glaucoma Specialist

If you have been diagnosed with glaucoma and are unsure whether your treatment is working, or if you have a family history and have never had a full nerve assessment, a second opinion is always appropriate. Early course correction protects what cannot be recovered.

📍 Dr Shibal Bhartiya — Marengo Asia Hospitals, Gurugram

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Glaucoma Test Results Explained: OCT, Visual Fields and Eye Pressure

Glaucoma test results are interpreted by combining OCT (optic nerve structure), visual fields (functional loss), and eye pressure, not in isolation. Early glaucoma can show normal vision but abnormal OCT or subtle field changes, which is why expert interpretation matters. A report may appear “normal” in one test but still show early glaucoma in another, especially on OCT.
Early glaucoma often has no symptoms, so small structural or functional changes matter more than how clearly you see.

Quick Interpretation Guide

Key rule: No single test confirms glaucoma; patterns + progression matter

OCT scan: Detects thinning of the optic nerve (early damage can appear here first)

Visual field test: Shows blind spots or peripheral vision loss (functional impact of disease)

Eye pressure (IOP): A risk factor, not a diagnosis, can be normal in glaucoma

Optic nerve exam: Assesses cupping and structural changes

If results are borderline or conflicting, progression over time, not a single test, determines diagnosis and treatment decisions. Dr Shibal Bhartiya, glaucoma specialist in Gurgaon, offers structured second opinions to interpret reports and guide treatment decisions.

Most patients arrive at a glaucoma consultation holding something. A folder. A USB drive. A stack of printouts from three different centres.

And one question: Is this serious? Do I need treatment?

That question is exactly right. The reports alone, however, cannot answer it.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Your Glaucoma Reports Create More Confusion Than Clarity

Each glaucoma test measures something different. Understanding what each one measures matters before you can understand what it means.

OCT scans measure structure. They calculate the thickness of the nerve fibre layer in your retina. Visual field tests measure function. They map what you can actually see and where gaps exist. Eye pressure is a risk factor, not a diagnosis. It can be elevated in people without glaucoma and normal in people who have it.

Looking at any one of these tests in isolation is misleading. Doctors who rely on a single test or a single visit miss what glaucoma actually is: a disease defined by change over time, not by a number on a report.


The Biggest Mistake Patients and Doctors Make

The most common mistake is treating a single report as the final word.

One abnormal OCT does not confirm glaucoma. One normal visual field does not rule it out. One eye pressure reading does not define your risk.

Glaucoma is not in the report. It is in the pattern over time.

A single snapshot, however detailed, tells you where you are today. It tells you nothing about where you are headed or how fast.


What Actually Matters When Reading Glaucoma Test Results

Consistency across tests. Structure and function should agree. When they do not, that disagreement is itself a clinical finding.

Change over time. Progression, not an absolute number, is how glaucoma causes irreversible harm. A stable OCT at 80 microns is far less alarming than one that dropped from 100 to 80 over two years.

Correlation with clinical examination. Disc photographs, gonioscopy, pachymetry, and a detailed history all shape what the reports mean. Printouts do not replace an examination.

A baseline to compare against. Without a baseline reading, no one can determine whether your results are stable or worsening. Many patients have no baseline at all.


When Your Glaucoma Reports Should Be Questioned

Some combinations of findings create decision traps rather than answers.

Your OCT shows an abnormality, but your visual fields are completely clean. The visual fields show loss, but the OCT looks normal. Your results vary significantly across different centres. You have no baseline to compare your current tests against.

These situations are not unusual. They are also not something a report can resolve on its own. They require clinical interpretation from someone who understands how these tests interact, and what normal variation looks like across different machines, populations, and clinical settings.

These are decision traps. They are not answers.


Why Indian Patients Need India-Specific Interpretation

Most OCT normative databases are built on Western populations. Indian eyes differ in optic disc size, retinal nerve fibre layer thickness, and axial length.

A result flagged as abnormal on a Western normative database may be entirely normal for an Indian patient. The reverse is also true. This is one reason why reports sometimes generate unnecessary alarm, and why population-matched interpretation matters.


What a Specialist Glaucoma Review Actually Involves

When I review a patient’s test results, I ask a specific set of questions.

Do the OCT findings and visual field findings agree? If not, which is more likely to represent true disease? Is there a baseline to compare against, and if so, what is the rate of change? Does the optic nerve appearance on examination match the measurements? What does the full risk profile show: including age, family history, corneal thickness, and relevant systemic factors?

That analysis is different from reading a printout. It is clinical reasoning built on pattern recognition across thousands of patients and many years of subspecialty practice in glaucoma.


The Goal Is Interpretation, Not More Tests

More tests rarely resolve confusion from existing tests. They add data without adding understanding.

If your reports have given you more confusion than clarity, you do not need another scan. You need someone who can put what you already have into clinical context, and tell you, with precision, whether you need to act, wait, or watch.

That is what a glaucoma consultation is for.

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.


Frequently Asked Questions: Understanding Glaucoma Test Results

Can normal eye pressure mean I do not have glaucoma?

Yes. Normal tension glaucoma is well-recognised and accounts for a significant proportion of glaucoma cases in India and Asia. Eye pressure is a risk factor, not a diagnostic threshold. Many patients with glaucoma have eye pressure readings within the statistically normal range. This is why pressure alone cannot confirm or exclude a diagnosis.

What does a thin OCT reading actually mean?

A thin OCT reading means that the nerve fibre layer in your retina measures below average. It does not automatically mean glaucoma. Thin readings can reflect natural anatomical variation, myopia, previous inflammation, or other conditions. A single thin OCT result requires correlation with your visual field test, your optic nerve appearance, and your history before any conclusion is drawn.

Can glaucoma be missed on a visual field test?

Yes. Visual field tests have limitations. Early structural damage to the optic nerve often precedes detectable functional loss on a visual field test by months or years. A normal visual field result does not exclude early glaucoma. It means function is preserved at that point in time. Serial testing over time is needed to detect progression.

How often should glaucoma tests be repeated?

The frequency depends on your individual risk profile and whether glaucoma or a suspect diagnosis has been established. Patients with confirmed glaucoma typically need visual fields and OCT every six to twelve months. Glaucoma suspects may need annual review. Your specialist will guide this based on your progression risk.

Why do my results vary across different hospitals or centres?

OCT results vary across different machine brands, software versions, and normative databases. Visual field results vary with patient fatigue, technique, and learning effect. Variation across centres is common and does not always indicate a change in your condition. Comparing tests done on the same machine type, at the same centre, over time gives the most reliable information.

What is the difference between glaucoma and a glaucoma suspect?

A glaucoma suspect is someone who has one or more features that raise concern: elevated eye pressure, a suspicious optic nerve, a thin retinal nerve fibre layer, a family history, or an equivocal visual field, but who does not yet meet the criteria for a glaucoma diagnosis. Suspects require regular monitoring because some will convert to glaucoma over time and some will not. Distinguishing the two requires careful longitudinal review.

When should I seek a second opinion on my glaucoma reports?

Seek a second opinion if your OCT and visual field results disagree persistently, if you have been told surgery is needed but your vision seems unchanged, if your reports vary significantly across centres, or if you have no baseline and cannot determine whether your condition is stable. A second opinion from a fellowship-trained glaucoma specialist can clarify your diagnosis and give you confidence in your treatment plan.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Cataract Surgery Does Not Protect You From Glaucoma

It is important to understand that cataract surgery does not protect you from glaucoma. Many patients believe that once they…

Glaucoma: Are you at risk?

Glaucoma usually has no symptoms in its early stages. By the time a patient notices something is wrong, significant and…